Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
157.60    3.80 (2.47%)
Bid:
157.60
Ask:
158.00
Spread: 0.40 (0.254%)
Market Cap: £385.03m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Update

24 May 2018 07:00

RNS Number : 0930P
Sabre Insurance Group PLC
24 May 2018
 

24 May 2018

 

SABRE INSURANCE GROUP PLC

Trading Update

Sabre Insurance Group plc (the "Group", or "Sabre"), one of the UK's leading private motor insurance underwriters, today publishes a trading update ahead of its AGM to be held later this morning.

Summary

· As set out in our 2017 full year results, in common with the rest of the motor market, we experienced competitive pricing in the last few weeks of 2017 which continued into the first two months of 2018 resulting in a modest reduction in premium income relative to the same period in 2017

 

· Pricing action was taken in early March to reflect the improving claims trends, specifically lower whiplash claims frequency, which has resulted in gross written premium ("GWP") returning to approximately 2017 levels on a weekly run-rate basis with no deterioration in our expected underwriting margins. Given this GWP for the year to 30 April 2018 is down year on year by around 5% at £69.8m(1) (2017: £73.1m(1))

 

· The Group continues to deliver leading underwriting performance supported by positive claims experience in the early months of 2018, and therefore reiterates the full year guidance for the 2018 underwriting performance reflecting a combined ratio slightly better than our long-term target of mid-70%'s

 

· A solvency ratio of over 188%(1) at the end of March exceeds our 140% - 160% target corridor, with organic capital being generated on a monthly basis

Geoff Carter, CEO, commented:

"Profitability of business written remains our key priority, with gross written premium and growth being an output rather than a target. Whilst we saw a reduction in premium income in the first two months of the year relative to the equivalent period last year, we took pricing action in early March which was supported by the emerging claims data. Following this action, volumes of new business on a weekly run-rate basis have returned to similar levels as the equivalent period in 2017 without any deterioration in expected underwriting margins. As such we remain confident in performing slightly better than our mid-70%'s combined ratio target for 2018, given our claims experience to date.

The motor market remains in a choppy state as competitors react to the early signs of changing claims patterns. Much uncertainty remains on the end state of these changes, not least around the critical Ogden discount rate which may impact overall claim costs and reinsurance pricing, making it difficult to predict the outcome for pricing and volumes for the remainder of the year and beyond. However, the market appears to have reacted rationally to reflect real-world changes in the cost of claims. Since we undertook our pricing action earlier this year we have seen no significant change in the pricing environment in our sector and, as such, currently expect our 2018 GWP position to be broadly in line with 2017. Assuming no changes to the current environment, we would expect modest GWP growth in 2019, without deterioration from our current underwriting margins.

In summary, we are encouraged by the start to the year. We remain absolutely committed to our core principle of underwriting discipline over GWP growth. We believe this will deliver a strong underwriting performance, and allow us to continue strengthening our capital position which will support the delivery of an attractive dividend, in line with our policy (stated at the time of the IPO) of paying out surplus capital by way of ordinary and special dividends."

(1) Numerical information not subject to audit

Media enquiries

Tulchan Communications LLP

James Macey White, Roger Tejwani & David Ison

020 7353 4200

sabre@tulchangroup.com

Investor enquiries

Sabre Insurance Group plc

Geoff Carter & Adam Westwood

0330 024 4696

adam.westwood@sabre.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEDFMDFASEFI
Date   Source Headline
2nd Jun 20267:00 amRNSOn-market Share Buyback Programme of £5m
27th May 20269:36 amRNSDirector Declaration
21st May 202611:20 amRNSResult of AGM
21st May 20267:00 amRNSTrading Update
12th May 20261:22 pmRNSDirector/PDMR Shareholding
22nd Apr 20261:18 pmRNSDirector/PDMR Shareholding
14th Apr 20263:48 pmRNSDirector/PDMR Shareholding
13th Apr 20263:18 pmRNSDirector/PDMR Shareholding
8th Apr 20262:56 pmRNSDirector/PDMR Shareholding
8th Apr 202610:41 amRNSDirector/PDMR Shareholding
8th Apr 202610:39 amRNSDirector/PDMR Shareholding
30th Mar 202611:01 amRNSNotice of AGM
11th Mar 20261:49 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSFull-year results 2025
11th Feb 20261:27 pmRNSDirector/PDMR Shareholding
13th Jan 20263:43 pmRNSDirector/PDMR Shareholding
11th Dec 20251:29 pmRNSDirector/PDMR Shareholding
11th Nov 20251:40 pmRNSDirector/PDMR Shareholding
31st Oct 20258:00 amRNSTotal Voting Rights
23rd Oct 20259:58 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTrading Update
14th Oct 20257:49 amRNSHolding(s) in Company
13th Oct 20253:56 pmRNSDirector/PDMR Shareholding
3rd Oct 20257:00 amRNSCompletion of Buyback Programme
3rd Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20257:00 amRNSTransaction in Own Shares
30th Sep 202510:21 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20251:01 pmRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20254:52 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 202512:24 pmRNSDirector/PDMR Shareholding
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.